In June 2023, RANZCP unveiled a clinical memorandum “Therapeutic Use of copyright Substances”. The purpose of the memo was to inform psychiatrists with regard to the probable therapeutic usage of copyright substances to guidance the treatment of mental illness. When selecting a pressu